DB Providing Public Health Analysis Support to CDC

In June, DB Consulting Group, Inc. (DB) was awarded its first task order under the Centers for Disease Control and Prevention Information Management Services (CIMS) contract. For the task order, DB provides public health analysis expertise, services, and support to the CDC’s Division of STD Prevention (DSTDP) in the National Center for HIV, Hepatitis, STD and TB Prevention (NCHHSTP). Major activities include:

  • Coordination of studies for DSTDP surveillance projects.
  • Preparation and review of project-related documents.
  • Managing and analyzing electronic data to interpret data, evaluate data quality, and prepare summary reports.
  • Communicating with public health surveillance partners.
  • Orientation and training of application users.
  • Providing technical assistance in support of the Gonococcal Isolate Surveillance Project (GISP) and STD Surveillance Network Project (SSuN) surveillance systems.
  • Ensuring proper documentation of work processes.
  • Data management and analysis.
  • “We are very excited about this opportunity to expand our partnership with CDC,” said DB Chief Executive Officer Gerald Boyd, Jr. “DB has enjoyed a successful working relationship with CDC since 2001, and we look forward to many more years of support and service to this top-notch health agency.”

    About CIMS
    In September, DB was named one of 30 prime contractors to be awarded a CIMS contract. Under this multiple award, indefinite delivery, indefinite quantity (IDIQ) contract, DB is eligible to bid on a variety of information management-related tasks that are issued by CDC. These services include: the planning, design, development, maintenance, engineering, integration, and retirement of information systems; the collection, analysis, and management of data, information, and knowledge; health information technology; public health informatics; graphics and web design; technical writing and editing; information security; and project and program management support.

    Comments are closed.